Table 2.
(a) Postoperative side effects according to the surgical approach (LRP = Laparoscopic versus RARP = Robotic-assisted). Number of cases and % of cases. Mean ± SD, median, (range). (b) Postoperative urinary continence results according to the surgical approach (LRP = Laparoscopic versus RARP = Robotic-assisted). Number of cases and % of cases and mean ± SD, median and range. (c) Postoperative sexual recovery results according to the surgical approach (LRP = Laparoscopic versus RARP = Robotic-assisted). Number of cases and % of cases and mean ± SD, median and range.
| (a) | |||
| Parameter | LRP | RARP | p Value |
| Postoperative anastomotic leakage | 0.245 | ||
| - No | 284(100%) | 157 (98.1%) | |
| - Yes | 0 | 3 (1.9%) | |
| Postoperative blood transfusion | 0.294 | ||
| - No | 284 (100%) | 158 (98.7%) | |
| - Yes | 0 | 2 (1.3%) | |
| Postoperative lymphocele | 0.16 | ||
| - No | 278 (97.9%) | 158 (98.7%) | |
| - Yes | 6 (2.1%) | 2 (1.3%) | |
| Postoperative anastomotic stricture | 0.51 | ||
| - No | 272 (95.8%) | 160 (100%) | |
| - Yes | 12 (4.2%) | 0 | |
| Postoperative rectal injury | x | ||
| - No | 824 (100%) | 160 (100%) | |
| - Yes | 0 | 0 | |
| Postoperative hospitalization (days) | 3.75 ± 0.74; 3 (3–7) | 3.11 ± 0.36; 3 (3–5) | 0.037 |
| Catheterization time (days) | 11.53 ± 1.45; 12 (8–14) | 9.60 ± 2.06; 10 (6–16) | <0.001 |
| (b) | |||
| Parameter | LRP | RARP | p Value |
| Postoperative Pelvic floor rehabilitation | 0.106 | ||
| - No | 230 (81.0%) | 125 (78.2%) | |
| - Yes | 54 (19.0%) | 33 (21.8%) | |
| Postoperative PAD test (1 month) (grams) | 163.84 ± 222.0; 50 (0–400) | 68.17 ± 374.17; 11 (0–404) | 0.68 |
| Postoperative PAD test (3 months (grams) | 75.57 ± 122.20; 20 (0–480) | 14.02 ± 42.09; 0 (0–250) | <0.001 |
| Postoperative PAD test (6 months) (grams) | 39.47 ± 76.08; 5 (0–420) | 13.62 ± 28.60; 0 (0–80) | 0.023 |
| Postoperative PAD test (12 months) (grams) | 14.76 ± 29.41; 0 (0–100) | 15.33 ± 23.2; 1 (0–50) | 0.964 |
| (c) | |||
| Parameter | LRP | RARP | p Value |
| Nerve sparing technique at surgery | <0.001 | ||
| - No | 223 (78.5%) | 94 (58%) | |
| - Yes | 61 (21.5%) | 66 (42%) | |
| Monolateral | 27 (43.3%) | 25 (31.7%) | |
| Bilateral | 34 (56.7%) | 41 (68.3%) | 0.187 |
| IIEF-5 postoperative (6 months) | 9.60 ± 3.78; 9 (6–19) | 10.25 ± 3.94; 9.5 (7–15) | 0.750 |
| IIEF-5 postoperative (12 months) | 10.14 ± 4.77; 10 (5–21) | 18.0 ± 3.75; 18 (18–18) | 0.117 |